Literature DB >> 24823489

Lymph node dissection for lung cancer: past, present, and future.

Shun-ichi Watanabe1.   

Abstract

In 1978, Naruke et al. proposed an anatomical map that included numbered lymph node stations, which then became widely used for nodal dissection. In 1997, Mountain and Dresler published a new map, which is now favored by the American Thoracic Society and the European Respiratory Society. Using these maps, regional nodal dissection has been universally performed in lung cancer surgery. Clear evidence regarding the survival benefit of lymph node dissection for lung cancer is lacking. However, lobectomy with lymph node dissection continues to be a standard surgical procedure for lung cancer because lymph node dissection is an important investigative process in staging patients. Over the last decade, the extent of nodal dissection for lung cancer has changed due to the increasing number of early detected lung cancers made possible by the recent development of the CT scanner. This manuscript describes the history, present strategy, and future perspectives of lymph node dissection for lung cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24823489     DOI: 10.1007/s11748-014-0412-z

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  59 in total

1.  Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis; clinicopathologic features and patterns of nodal spread.

Authors:  Shun-ichi Watanabe; Makoto Oda; Yoshio Tsunezuka; Tetsuhiko Go; Yasuhiko Ohta; Go Watanabe
Journal:  Eur J Cardiothorac Surg       Date:  2002-12       Impact factor: 4.191

2.  Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection.

Authors:  M Oda; Y Watanabe; J Shimizu; S Murakami; Y Ohta; N Sekido; S Watanabe; N Ishikawa; A Nonomura
Journal:  Lung Cancer       Date:  1998-10       Impact factor: 5.705

3.  Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis.

Authors:  R E Dales; R M Stark; S Raman
Journal:  Am Rev Respir Dis       Date:  1990-05

4.  Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

5.  A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.

Authors:  Yi long Wu; Zhi-fan Huang; Si-yu Wang; Xue-ning Yang; Wei Ou
Journal:  Lung Cancer       Date:  2002-04       Impact factor: 5.705

6.  Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection.

Authors:  M Okada; N Tsubota; M Yoshimura; Y Miyamoto
Journal:  J Thorac Cardiovasc Surg       Date:  1998-12       Impact factor: 5.209

7.  Mediastinal nodal involvement and the prognosis of non-small cell lung cancer.

Authors:  Y Watanabe; Y Hayashi; J Shimizu; M Oda; T Iwa
Journal:  Chest       Date:  1991-08       Impact factor: 9.410

8.  Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.

Authors:  Steven M Keller; Mark G Vangel; Henry Wagner; Joan H Schiller; Arnold Herskovic; Ritsuko Komaki; Randolph S Marks; Michael C Perry; Robert B Livingston; David H Johnson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

9.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

10.  Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer.

Authors:  A N Graham; K J Chan; U Pastorino; P Goldstraw
Journal:  J Thorac Cardiovasc Surg       Date:  1999-02       Impact factor: 5.209

View more
  10 in total

Review 1.  The lymphatic vasculature: An active and dynamic player in cancer progression.

Authors:  Sara Rezzola; Elena C Sigmund; Cornelia Halin; Roberto Ronca
Journal:  Med Res Rev       Date:  2021-09-05       Impact factor: 12.388

2.  The Prognostic Impact of Lymph Node Dissection on Primary Tumor Resection for Stage IV Non-Small Cell Lung Cancer: A Population-Based Study.

Authors:  Yudong Zhang; Yichi Zhang; Xinxin Cheng; Keyao Dai; Bo Xu; Shujun Liang; Minsheng Chen; Honglang Zhang; Zhenguang Chen
Journal:  Front Oncol       Date:  2022-05-05       Impact factor: 5.738

3.  Intraoperative frozen sections of the regional lymph nodes contribute to surgical decision-making in non-small cell lung cancer patients.

Authors:  Wei Li; Xue-Ning Yang; Ri-Qiang Liao; Qiang Nie; Song Dong; Hao-Ran Zhai; Yi-Long Wu; Wen-Zhao Zhong
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

4.  Comparison of treatment outcomes between single-port video-assisted thoracoscopic anatomic segmentectomy and lobectomy for non-small cell lung cancer of early-stage: a retrospective observational study.

Authors:  Yuxing Lin; Wei Zheng; Yong Zhu; Zhaohui Guo; Bin Zheng; Chun Chen
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

5.  Comparison between robot-assisted thoracoscopic surgery and video-assisted thoracoscopic surgery for mediastinal and hilar lymph node dissection in lung cancer surgery.

Authors:  Tomohiro Haruki; Yuzo Takagi; Yasuaki Kubouchi; Yoshiteru Kidokoro; Atsuyuki Nakanishi; Yuji Nozaka; Yuki Oshima; Shinji Matsui; Hiroshige Nakamura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-18

6.  Tumor volume is more reliable to predict nodal metastasis in non-small cell lung cancer of 3.0 cm or less in the greatest tumor diameter.

Authors:  Bei Jia; Biao Chen; Hao Long; Tiehua Rong; Xiaodong Su
Journal:  World J Surg Oncol       Date:  2020-07-15       Impact factor: 2.754

7.  Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lung.

Authors:  DengGuo Zhang; XianChao Chen; Daxin Zhu; Changlong Qin; Jingsi Dong; Xiaoming Qiu; Mingyu Fan; QingHua Zhuo; XiaoJun Tang
Journal:  Thorac Cancer       Date:  2018-11-23       Impact factor: 3.500

8.  [To Explore Clinical Value of Single-port Video-assisted Thoracoscopic Surgery 
in Elderly Patients with Non-small Cell Lung Cancer: Lobectomy, Segmentectomy 
and Lobectomy vs Segmentectomy].

Authors:  Lin Huang; Bin Zheng; Chun Chen; Wei Zheng; Yong Zhu; Chaohui Guo
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-04-20

9.  Significance of risk factor analysis and dissection for station 4L lymphatic metastasis in left lung cancer: a systematic review and meta-analysis.

Authors:  Chu-Xu Wang; Chun Xu; Chang Li; Cheng Ding; Jun Chen; Jun Zhao
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

10.  Lymph Node Dissection Is a Risk Factor for Short-Term Cough after Pulmonary Resection.

Authors:  Xiaoli Wu; Hanyang Xing; Ping Chen; Jihua Ma; Xintian Wang; Chengyi Mao; Xiaoying Zhao; Fuqiang Dai
Journal:  Curr Oncol       Date:  2022-01-10       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.